Anixa Biosciences (ANIX) Long-Term Investments (2010 - 2014)
Anixa Biosciences' Long-Term Investments was $4.15 million in fiscal Q3 2014 (quarter ended Jul 31, 2014), down 2.8% from $4.27 million a year earlier but up 4.4% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Long-Term Investments (2010 - 2014) Analysis & Trends
At the end of FY2013 (ended Oct 31, 2013), Long-Term Investments at Anixa Biosciences came in at $4.2 million, down 11.2% from FY2012.
- Long-Term Investments shows a three-year compound annual growth rate of 220.5% (FY2010 to FY2013).
- In earlier fiscal years, Long-Term Investments was $4.73 million in FY2012 (-12.1%), $5.38 million in FY2011 and $127,500 in FY2010.
- Quarterly Long-Term Investments has moved between $127,500 (fiscal Q4 2010) and $7.11 million (fiscal Q3 2011) over five years.
- Compared with a year earlier, Long-Term Investments has declined for four straight quarters, with an average decline of 18.1% over the last five quarters.
- Per Business Quant data, ANIX's Long-Term Investments in the three fiscal quarters before Q3 2014 was $3.98 million (Q2 2014), $3.99 million (Q1 2014) and $4.2 million (Q4 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Anixa Biosciences | 101.52 Mn | 87.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2014 | 4.15 Mn |
| Apr 30, 2014 | 3.98 Mn |
| Jan 31, 2014 | 3.99 Mn |
| Oct 31, 2013 | 4.20 Mn |
| Jul 31, 2013 | 4.27 Mn |
| Apr 30, 2013 | 6.02 Mn |
| Jan 31, 2013 | 5.73 Mn |
| Oct 31, 2012 | 4.73 Mn |
| Jul 31, 2012 | 127,500.00 |
| Apr 30, 2012 | 127,500.00 |
| Jan 31, 2012 | 127,500.00 |
| Oct 31, 2011 | 5.38 Mn |
| Jul 31, 2011 | 7.11 Mn |
| Oct 31, 2010 | 127,500.00 |
API Access
Anixa Biosciences Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();